EVERSANA is a 7000+-person private-equity backed global commercialization platform for life science products. Our integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. We proudly serve over 650+ organizations, including innovative start-ups and established pharmaceutical companies, to advance life science solutions for a healthier world.
EVERSANA will be at BIO 2026 and would love to meet with you to discuss:
- COMMERCIALIZATION PARTNERSHIPS
EVERSANA COMPLETE Commercialization® is helping manufacturers seeking to launch their own product while limiting the cost of building infrastructure, reducing risk, maintaining full ownership, and capturing full revenue potential through maturity.
- COMMERCIALIZATION ACROSS GLOBAL MARKETS
We are constantly evolving and adapting to solve the complex challenges our clients are facing in local and global markets.
Meet us at BIO 2026 to learn more.
